ENTITY

Biomarin Pharmaceutical (BMRN US)

57
Analysis
Health CareUnited States
BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
more
Refresh
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x